About JMB Pharmaceuticals
JMB Pharmaceuticals is a Healthcare company based in India. Pharmaceutical formulations and veterinary products manufacturing in Mumbai. Its Indian entity Jmb Pharmaceuticals Private Limited reported revenue of ₹25.18 Cr. JMB Pharmaceuticals offers products and services including Pharmaceutical Formulations and Veterinary Products. Its focus areas include Pharmaceuticals, Drug Manufacturing, Formulations and Veterinary Services.
Company details
JMB Pharmaceuticals is known for delivering healthcare solutions through a diverse portfolio of pharmaceutical products that are developed and exported globally. High-quality formulations for human use and veterinary care, including active ingredients and surgical disposables, are supplied to meet worldwide demands. The company emphasizes values like integrity and quality, while maintaining accreditations and a strong presence in markets such as Turkmenistan. Employee skills are upgraded through development initiatives, and participation in international conferences is ensured to foster global connections. Operations are based in Mumbai, India, focusing on affordable medicines that sustain well-being.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Website jmbpharma.com
- Social LinkedIn
- Legal Name Jmb Pharmaceuticals Pvt. Ltd
- Date of Incorporation 28 Jul, 2014
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹25.18 Cr
FY 2024 · +22% YoY
- Net Profit₹1.27 Cr
FY 2024 · 5% margin
- EBITDA₹2.04 Cr
FY 2024 · 8% margin
Associated legal entities of JMB Pharmaceuticals
JMB Pharmaceuticals operates through Jmb Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jmb Pharmaceuticals Private Limited CIN U32503MH2014PTC256657 | Active | 28 Jul 2014 | Mumbai, Maharashtra | ₹25.2 Cr | 2 | View details |
Products & Services of JMB Pharmaceuticals
JMB Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Veterinary Products.
Pharmaceutical formulations for human use are supplied globally, covering a diverse portfolio of drugs across various therapies.
Veterinary products, including medicines and feed supplements for livestock and companion animals, are marketed in therapeutic segments like parasiticides and vaccines.
Board of directors of Jmb Pharmaceuticals Private Limited (JMB Pharmaceuticals)
Jmb Pharmaceuticals Private Limited is the primary company behind JMB Pharmaceuticals. The board of Jmb Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Benno John Nangani, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Benno John Nangani DIN 00036740 | Director | 28 Jul 2014 | 12 yrs 3 mo | Jmb Pharmaceuticals Private Limited |
| John Benno Marina DIN 06903935 | Director | 30 Nov 2021 | 4 yrs 11 mo | Jmb Pharmaceuticals Private Limited |
Financials of JMB Pharmaceuticals
Figures of Jmb Pharmaceuticals Private Limited, the primary company behind JMB Pharmaceuticals, for FY 2024. Revenue was ₹25.18 Cr (+22% year on year). Net profit was ₹1.27 Cr (5% margin). EBITDA was ₹2.04 Cr (8% margin). Revenue has grown at a compounded annual rate of +22% over three years and +13% over five years.
- ₹25.18 CrRevenue · FY 2024 · +22% YoY
- ₹1.27 CrNet profit · 5% margin
- ₹2.04 CrEBITDA · 8% margin
- ₹85 LakhPaid-up capital
- +22%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jmb Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for JMB Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about JMB Pharmaceuticals
JMB Pharmaceuticals is headquartered in India.
The primary company behind JMB Pharmaceuticals, Jmb Pharmaceuticals Private Limited, reported revenue of ₹25.18 Cr for FY 2024, up 22% year on year.
JMB Pharmaceuticals is known for delivering healthcare solutions through a diverse portfolio of pharmaceutical products that are developed and exported globally. High-quality formulations for human use and veterinary care, including active ingredients and surgical disposables, are supplied to meet worldwide demands. The company emphasizes values like integrity and quality, while maintaining accreditations and a strong presence in markets such as Turkmenistan. Employee skills are upgraded through development initiatives, and participation in international conferences is ensured to foster global connections. Operations are based in Mumbai, India, focusing on affordable medicines that sustain well-being.
JMB Pharmaceuticals offers Pharmaceutical Formulations and Veterinary Products.
JMB Pharmaceuticals operates through Jmb Pharmaceuticals Private Limited.
The legal entities of JMB Pharmaceuticals currently have 2 directors, including John Benno Marina, Benno John Nangani.